Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer (Scientific Reports, 2019)

(untitled) - Schmid, V; Lafleur, V; Lombardi, O; Li, R; Salama, R; Colli, L; Choudhry, H; Chanock, S; Ratcliffe, P; Mole, D